Australia's current COVID-19 treatment options, and why the national death rate is so high

Australia's current COVID-19 treatment options, and why the national fatility rate is so high
Posted Yesterday at 8:00pm
SatSaturday 3
updated 1
AprApril 2021 at 9:25am
Older people and people with compromised immune systems are more at risk of severe illness or death from COVID-19.
(
Share
Print text only
Cancel
As Australia's vaccine rollout eases — slowly — into its second phase, experts are pausing to reflect on how far we've come with COVID-19 treatments and what the prospects are for saving more lives.
US-based Craig Rayner sits on the World Health Organization’s therapeutics committee for COVID-19.
"From a global view, we started off really with a mad dash to look for anything that we could re-purpose," said Dr Rayner, who is the president of integrated drug development at the company Certara.

Related Keywords

Australia , Monash , South Australia , United States , Australian , Craig Rayner , Carl Kirkpatrick , Pfizer , Astrazeneca , Australia Doherty Institute , Monash University , World Health Organization , Doherty Institute , Professor Kirpatrick , Professor Kirk Patrick , Vaccine , Vaccine Development , Covid Treatments , Covid Treatments Australia , Treatment Australia , ஆஸ்திரேலியா , மோனாஷ் , தெற்கு ஆஸ்திரேலியா , ஒன்றுபட்டது மாநிலங்களில் , ஆஸ்திரேலிய , கிரேக் ரேநர் , கார்ல் கர்க்‌ப்யாட்ரிக் , ஃபைசர் , ஆஸ்திரேலியா டோவர்டீ நிறுவனம் , மோனாஷ் பல்கலைக்கழகம் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , டோவர்டீ நிறுவனம் , தடுப்பூசி , தடுப்பூசி வளர்ச்சி , சிகிச்சை ஆஸ்திரேலியா ,